title: Tissue factor in tumor microenvironment: a systematic review.
abstract: The aberrant hemostasis is a common manifestation of cancer, and venous thromboembolism (VTE) is the second leading cause of cancer patients' mortality. Tissue factor (TF), comprising of a 47-kDa transmembrane protein that presents in subendothelial tissues and leukocytes and a soluble isoform, have distinct roles in the initiation of extrinsic coagulation cascade and thrombosis. Laboratory and clinical evidence showed the deviant expression of TF in several cancer systems and its tumor-promoting effects. TF contributes to myeloid cell recruitment in tumor stroma, thereby remodeling of tumor microenvironment. Additionally, the number of TF-positive-microparticles (TF+MP) from tumor origins correlates with the VTE rates in cancer patients. In this review, we summarize our current understanding of the TF regulation and roles in tumor progression and clinical complications.
authors.forename: Xiao
authors.initials: X
authors.lastname: Han
authors.forename: Bo
authors.initials: B
authors.lastname: Guo
authors.forename: Yongsheng
authors.initials: Y
authors.lastname: Li
authors.forename: Bo
authors.initials: B
authors.lastname: Zhu
mesh_terms: D000818:Animals; D001777:Blood Coagulation / Q000502:physiology; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000473:pathology*; D013925:Thromboplastin / Q000378:metabolism*; D059016:Tumor Microenvironment / Q000502:physiology*; D054556:Venous Thromboembolism / Q000209:etiology / Q000378:metabolism / Q000473:pathology
chemical_list: D013925:Thromboplastin
references.citation: Front Biosci (Landmark Ed). 2011 Jun 01;16:3061-71
references.pmid: 21622222
references.citation: Blood. 2012 Jan 26;119(4):924-32
references.pmid: 22065595
references.citation: Thromb Res. 2012 Apr;129 Suppl 1:S127-31
references.pmid: 22682123
references.citation: Nat Med. 1996 Feb;2(2):209-15
references.pmid: 8574967
references.citation: Mol Cell Biochem. 2013 Aug;380(1-2):239-47
references.pmid: 23666757
references.citation: J Nucl Med. 2012 Nov;53(11):1748-54
references.pmid: 22988057
references.citation: Blood. 2013 Sep 19;122(12):2011-8
references.pmid: 23908470
references.citation: Semin Thromb Hemost. 2008 Mar;34(2):161-9
references.pmid: 18645921
references.citation: Thromb Haemost. 2002 Jun;87(6):930-6
references.pmid: 12083498
references.citation: Eur J Cancer. 2011 Sep;47(14):2230-9
references.pmid: 21621407
references.citation: Thromb Res. 2011 Feb;127(2):141-8
references.pmid: 21168190
references.citation: Blood. 2010 Aug 5;116(5):815-8
references.pmid: 20462964
references.citation: Exp Cell Res. 1999 Apr 10;248(1):136-47
references.pmid: 10094821
references.citation: Circ Res. 2005 Jun 24;96(12):1233-9
references.pmid: 15920023
references.citation: Nat Med. 2003 Apr;9(4):458-62
references.pmid: 12652293
references.citation: Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11517-22
references.pmid: 23801760
references.citation: Cancer Res. 2009 Mar 15;69(6):2540-9
references.pmid: 19276385
references.citation: Hamostaseologie. 2012;32(2):115-25
references.pmid: 21971578
references.citation: Eur J Clin Invest. 2013 Mar;43(3):277-85
references.pmid: 23398637
references.citation: Cancer Res. 1996 Nov 1;56(21):5063-70
references.pmid: 8895765
references.citation: Cancer Res. 2011 Oct 15;71(20):6492-502
references.pmid: 21880589
references.citation: Vet Immunol Immunopathol. 2013 May 15;153(1-2):17-25
references.pmid: 23465358
references.citation: Am J Respir Cell Mol Biol. 2012 Nov;47(5):614-27
references.pmid: 22771387
references.citation: Thromb Haemost. 2001 Dec;86(6):1353-9
references.pmid: 11776298
references.citation: Blood. 2012 Mar 29;119(13):3164-75
references.pmid: 22327225
references.citation: Proc Natl Acad Sci U S A. 1987 Aug;84(15):5148-52
references.pmid: 3037536
references.citation: Tumour Biol. 2013 Apr;34(2):837-46
references.pmid: 23233043
references.citation: Semin Thromb Hemost. 2010 Nov;36(8):888-906
references.pmid: 21049390
references.citation: Exp Lung Res. 2011 Oct;37(8):509-17
references.pmid: 21913843
references.citation: Neuro Oncol. 2012 Sep;14 Suppl 4:iv73-80
references.pmid: 23095833
references.citation: Nat Med. 2004 Aug;10(8):789-99
references.pmid: 15286780
references.citation: Thromb Haemost. 2013 Jul;110(1):14-22
references.pmid: 23615656
references.citation: J Thromb Haemost. 2007 Apr;5(4):729-37
references.pmid: 17408406
references.citation: Blood. 2013 Apr 18;121(16):3289-97
references.pmid: 23407548
references.citation: Immunity. 2013 Mar 21;38(3):541-54
references.pmid: 23477736
references.citation: Acta Oncol. 2013 May;52(4):842-51
references.pmid: 23409769
references.citation: J Thromb Haemost. 2007 Mar;5(3):520-7
references.pmid: 17166244
references.citation: Circ J. 2009 Sep;73(9):1746-52
references.pmid: 19597299
references.citation: J Thromb Haemost. 2009 Aug;7(8):1421-3
references.pmid: 19500241
references.citation: Nat Immunol. 2008 Nov;9(11):1225-35
references.pmid: 18820683
references.citation: Exp Cell Res. 2013 Jan 15;319(2):126-32
references.pmid: 22999864
references.citation: Circ Res. 2011 May 13;108(10):1284-97
references.pmid: 21566224
references.citation: Semin Thromb Hemost. 2008 Mar;34(2):154-60
references.pmid: 18645920
references.citation: Thromb Haemost. 2007 Jan;97(1):11-4
references.pmid: 17200764
references.citation: Trends Cardiovasc Med. 2014 Apr;24(3):128-32
references.pmid: 24120358
references.citation: J Thromb Haemost. 2011 Oct;9(10):1985-92
references.pmid: 21794077
references.citation: Stem Cells. 2012 Oct;30(10):2309-19
references.pmid: 22887854
references.citation: J Surg Oncol. 2007 Mar 15;95(4):324-31
references.pmid: 17066404
references.citation: Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):15-26
references.pmid: 21160064
references.citation: Oncol Rep. 2011 Sep;26(3):665-70
references.pmid: 21617868
references.citation: J Thromb Haemost. 2008 May;6(5):812-9
references.pmid: 18315549
references.citation: BMC Cancer. 2011 Jun 22;11:263
references.pmid: 21693061
references.citation: Blood. 2005 Feb 15;105(4):1734-41
references.pmid: 15494427
references.citation: Int J Cancer. 2015 Aug 1;137(3):497-503
references.pmid: 24806794
references.citation: Int J Lab Hematol. 2012 Aug;34(4):396-402
references.pmid: 22348286
references.citation: Asian Pac J Cancer Prev. 2012;13(5):1845-9
references.pmid: 22901134
references.citation: Chem Biol. 2011 Jan 28;18(1):67-76
references.pmid: 21276940
references.citation: Circ Res. 2009 Mar 13;104(5):589-99
references.pmid: 19168442
references.citation: Thromb Res. 2007;120 Suppl 2:S13-21
references.pmid: 18023707
references.citation: Expert Rev Hematol. 2013 Feb;6(1):91-101
references.pmid: 23373784
references.citation: Thromb Res. 2013 Aug;132(2):180-4
references.pmid: 23856554
references.citation: Thrombosis. 2013;2013:948765
references.pmid: 24288605
references.citation: J Thromb Haemost. 2004 Nov;2(11):2065-7
references.pmid: 15550054
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2130-5
references.pmid: 15699479
references.citation: Int J Colorectal Dis. 2011 May;26(5):593-601
references.pmid: 21404058
references.citation: Cancer Res. 1996 May 15;56(10):2452-7
references.pmid: 8625327
references.citation: Mol Biol Cell. 2004 Oct;15(10):4416-25
references.pmid: 15254262
references.citation: Circ J. 2011;75(5):1235-42
references.pmid: 21389637
references.citation: Blood Coagul Fibrinolysis. 2013 Apr;24(3):339-43
references.pmid: 23524311
references.citation: Carcinogenesis. 2009 Jul;30(7):1089-96
references.pmid: 19359592
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19497-502
references.pmid: 19875693
references.citation: Thromb Haemost. 2007 Jan;97(1):119-23
references.pmid: 17200778
references.citation: N Engl J Med. 2003 Jul 10;349(2):109-11
references.pmid: 12853582
references.citation: Clin Cancer Res. 2009 Nov 15;15(22):6830-40
references.pmid: 19861441
references.citation: Thromb Res. 2012 Apr;129 Suppl 1:S22-9
references.pmid: 22682129
references.citation: Oncologist. 2013;18(1):14-8
references.pmid: 23287882
references.citation: Thromb Res. 2010 Apr;125 Suppl 2:S84-8
references.pmid: 20434014
references.citation: Thromb Res. 2012 Apr;129 Suppl 1:S1-5
references.pmid: 22682116
references.citation: Circulation. 2005 Jan 25;111(3):349-55
references.pmid: 15642762
references.citation: Cancer Res. 2011 Jan 15;71(2):614-24
references.pmid: 21224357
references.citation: J Thromb Haemost. 2012 Nov;10(11):2242-53
references.pmid: 23006890
references.citation: PLoS One. 2013;8(2):e56557
references.pmid: 23437168
references.citation: Semin Thromb Hemost. 2006 Apr;32 Suppl 1:61-8
references.pmid: 16673267
references.citation: Blood. 2012 Aug 23;120(8):1717-25
references.pmid: 22802338
references.citation: J Thromb Haemost. 2007 Jan;5(1):70-4
references.pmid: 17239164
references.citation: J Thromb Haemost. 2008 May;6(5):877-84
references.pmid: 18315555
references.citation: Oncol Rep. 2013 Jul;30(1):462-70
references.pmid: 23604472
references.citation: J Surg Oncol. 2012 Nov;106(6):689-95
references.pmid: 22532129
references.citation: Cancer Res. 2008 Dec 15;68(24):10068-76
references.pmid: 19074872
references.citation: Int J Gynecol Cancer. 2011 May;21(4):616-24
references.pmid: 21543928
references.citation: Mol Med. 2012 Jul 18;18:771-9
references.pmid: 22481268
references.citation: Tumour Biol. 2013 Oct;34(5):2573-81
references.pmid: 23616010